Prestige Consumer Healthcare (PBH) Other Non-Current Liabilities (2013 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Other Non-Current Liabilities of $5.7 million in Q4 2025, up 6.84% quarter-over-quarter from $5.4 million in Q3 2025, and up 14.28% on a YoY basis from $5.0 million in Q4 2024.
Prestige Consumer Healthcare (PBH) Other Non-Current Liabilities (2013 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Other Non-Current Liabilities history runs 13 years deep, the most recent figure standing at $5.7 million for Q4 2025.
- In Q4 2025, Other Non-Current Liabilities rose 14.28% year-over-year to $5.7 million; the TTM figure through Dec 2025 stood at $5.7 million (up 14.28% YoY), while the FY2025 annual figure was $5.4 million, down 41.31% from the prior year.
- Other Non-Current Liabilities was $5.7 million for Q4 2025 at Prestige Consumer Healthcare, up from $5.4 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $9.2 million in Q1 2024 to a low of $5.0 million in Q4 2024.
- Historically, Other Non-Current Liabilities has averaged $7.4 million across 5 years, with a median of $8.3 million in 2021.
- The sharpest annual moves came in 2021 and 2025: Other Non-Current Liabilities slumped 66.15% in 2021, then rose 14.28% in 2025.
- A 5-year view of Other Non-Current Liabilities shows it stood at $8.4 million in 2021, then rose by 5.21% to $8.9 million in 2022, then rose by 0.53% to $8.9 million in 2023, then tumbled by 43.61% to $5.0 million in 2024, then grew by 14.28% to $5.7 million in 2025.
- The last three Other Non-Current Liabilities figures came in at $5.7 million (Q4 2025), $5.4 million (Q3 2025), and $5.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | 157.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.75 Mn |
| Sep 30, 2025 | 5.38 Mn |
| Jun 30, 2025 | 5.41 Mn |
| Mar 31, 2025 | 5.39 Mn |
| Dec 31, 2024 | 5.03 Mn |
| Sep 30, 2024 | 5.12 Mn |
| Jun 30, 2024 | 5.14 Mn |
| Mar 31, 2024 | 9.19 Mn |
| Dec 31, 2023 | 8.92 Mn |
| Sep 30, 2023 | 8.90 Mn |
| Jun 30, 2023 | 8.18 Mn |
| Mar 31, 2023 | 8.17 Mn |
| Dec 31, 2022 | 8.87 Mn |
| Sep 30, 2022 | 8.88 Mn |
| Jun 30, 2022 | 8.92 Mn |
| Mar 31, 2022 | 7.48 Mn |
| Dec 31, 2021 | 8.43 Mn |
| Sep 30, 2021 | 8.49 Mn |
| Jun 30, 2021 | 8.56 Mn |
| Mar 31, 2021 | 8.61 Mn |